Gene · 10921
RNPS1: RNA binding protein with serine rich domain 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RNPS1: RNA binding protein with serine rich domain 1. Genes, record 10921. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10921
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15287 | RNA-binding protein with serine-rich domain 1 | 305 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents68
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 4096 | Q15287 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4096 | Q15287 | Espacenet |
| EP 4519435 A2 | 2025-03-12 | 143 | Q15287 | Espacenet |
| JP 2024178415 A | 2024-12-24 | 486 | Q15287 | Espacenet |
| JP 2024178415 A | 2024-12-24 | 487 | Q15287 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4890 | Q15287 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4891 | Q15287 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4892 | Q15287 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 5213 | Q15287 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 5420 | Q15287 | Espacenet |
1 to 10 of 68
See all 68 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,020
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RNPS1 papers | Newest fiscal year |
|---|---|---|---|
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 17 | 2025 |
| R01GM042699 | Biochemistry of Pre-mRNA Splicing | 15 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 12 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 8 | 2025 |
| R01HL128239 | Genetic and molecular basis for SRSF2 mutations in myelodysplasia | 7 | 2025 |
| ZIASC010357 | Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA034196 | Cancer Center Support (CORE) Grant | 4 | 2025 |
1 to 10 of 1,020Source NIH's project files
See all 1,020 nih grantsPapers1,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assembly of exon junction complexes on spliceosomes begins before spliceosome activation. | Nucleic Acids Res | 2026 | 42635127 | PubTator, text mining | PubMed |
| Large-scale tethered screen of RNA-binding proteins reveals novel regulators of poly(A) site selection. | Mol Cell | 2026 | 42361791 | PubTator, text mining | PubMed |
| Characterization of flexible RNA binding by tandem RNA recognition motifs through integrative ensemble modelling. | Nucleic Acids Res | 2026 | 41914502 | PubTator, text mining | PubMed |
| Identification of stable reference genes in plasma astrocyte-derived exosomal mRNA for RT-qPCR analysis in Alzheimer's disease. | Biochem Biophys Res Commun | 2026 | 41865408 | PubTator, text mining | PubMed |
| RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms. | iScience | 2026 | 41797923 | PubTator, text mining | PubMed |
| RNA localization to nuclear speckles follows splicing logic. | Nucleic Acids Res | 2026 | 41787512 | PubTator, text mining | PubMed |
| XQ2, a Novel Derivative of Resveratrol, Reactivates Latent HIV‑1 via the Activation of Positive Transcription Elongation Factor B. | ACS Omega | 2026 | 41768657 | PubTator, text mining | PubMed |
| U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner. | Nucleic Acids Res | 2026 | 41761909 | PubTator, text mining | PubMed |
| Cell modeling and rescue of a novel noncoding genetic cause of glycogen storage disease IX. | Genet Med Open | 2026 | 41716687 | PubTator, text mining | PubMed |
| Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. | Cell Oncol (Dordr) | 2026 | 41636961 | PubTator, text mining | PubMed |
1 to 10 of 1,530
See all 1,530 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10921
GET https://conductscience.org/api/genes/v1/10921/patents?page=2